Study summary

This study assessed analgesic efficacy of ASP0819 relative to placebo as well as the safety and tolerability.

This study assessed treatment differences in physical function as well as the improvements in overall subject status (e.g., fibromyalgia symptoms and global functioning) of ASP0819 relative to placebo.

Additional Study Details

Phase
Phase 2
Product
  • ASP0819
  • Placebo
  • Type
    Interventional
    Masking
    Double (Participant, Investigator)
    Enrollment number
    186
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English
    Protocol
    Available Language(s): English
    Statistical Analysis Plan (SAP)
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients with Fibromyalgia? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site US10055 - Central Kentucky Research Asc
      Lexington, KY, United States, 40509
      Completed
      Site US10059 - Hillcrest Clinical
      Oklahoma City, OK, United States, 73119
      Completed
      Site US10006 - Columbus Regional Research Ins
      Columbus, GA, United States, 31904
      Completed
      Site US10018 - Altea Research Institute
      Las Vegas, NV, United States, 89102
      Completed
      Site US10005 - Charlottesville Med Research
      Charlottesville, VA, United States, 22911
      Completed
      Site US10031 - Wake Research Associates
      Raleigh, NC, United States, 27612
      Completed
      Site US10012 - Palm Beach Research Center
      West Palm Beach, FL, United States, 33409
      Completed
      Site US10003 - Artemis Inst For Clin Research
      San Diego, CA, United States, 92103
      Completed
      Site US10037 - Dept of Psychiatry and Neuro University of Cincinnati
      Cincinnati, OH, United States, 45219
      Completed
      Site US10019 - Lillestol Research LLC
      Fargo, ND, United States, 58103
      Completed
      Site US10039 - Superior Research LLC
      Sacramento, CA, United States, 95831
      Completed
      Site US10028 - Renstar Medical Research
      Ocala, FL, United States, 34471
      Completed
      Site US10038 - Heartland Research Associates
      Wichita, KS, United States, 67205
      Completed
      Site US10024 - Compass Research LLC
      Orlando, FL, United States, 32806
      Completed
      Site US10010 - Upstate Clinical Research Asc
      Williamsville, NY, United States, 14221
      Completed
      Site US10032 - Peters Medical Research
      High Point, NC, United States, 27262
      Completed
      Site US10023 - Oregon Ctr for Clinical Invest
      Salem, OR, United States, 97301
      Completed
      Site US10045 - TriWest Research Associates
      El Cajon, CA, United States, 92020
      Completed
      Site US10025 - Achieve Clinical Research, LLC
      Birmingham, AL, United States, 35216
      Completed
      Site US10013 - Bateman Horne Center
      Salt Lake City, UT, United States, 84102
      Completed
      Site US10027 - BTC of New Bedford LLC
      New Bedford, MA, United States, 02740
      Completed
      Site US10056 - Atlanta Ctr for Med Research
      Atlanta, GA, United States, 30331
      Completed
      Site US10043 - Oregon Ctr for Clinical Invest
      Portland, OR, United States, 97214
      Completed
      Site US10048 - Diablo Clinical Research Inc
      Walnut Creek, CA, United States, 94598
      Withdrawn
      Site US10035 - McIlwain Medical Research
      Tampa, FL, United States, 33614

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?